{"id":406,"date":"2026-09-30T02:42:13","date_gmt":"2026-09-30T06:42:13","guid":{"rendered":"https:\/\/pauseproof.com\/articles\/?p=406"},"modified":"2026-10-21T02:09:15","modified_gmt":"2026-10-21T06:09:15","slug":"hormone-replacement-therapy-for-perimenopause","status":"publish","type":"post","link":"https:\/\/pauseproof.com\/articles\/hormone-replacement-therapy-for-perimenopause\/","title":{"rendered":"Hormone Replacement Therapy for Perimenopause: NICE, Quoted"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Hormone replacement therapy for perimenopause falls under the same NICE recommendations as menopause, and none of them requires periods to have stopped. NICE says to offer HRT for hot flushes and sweats, to consider it for depressive symptoms that arrive with other menopause symptoms, and not to offer it to prevent heart disease or dementia.<\/strong><\/p>\n\n\n\n<div class=\"msq-audio\" data-article=\"hormone-replacement-therapy-for-perimenopause\" data-minutes=\"15\">\n<style>.msq-audio{margin:1.25em 0 1.75em;padding:16px 18px;background:#F5EFF5;border:1px solid #DDD0DF;border-radius:12px}\n.msq-audio-lead{margin:0 0 8px;font-size:.95em}.msq-audio audio{width:100%;margin:0 0 12px;display:block}\n.msq-toc-title{margin:0 0 6px;font-weight:700}.msq-toc ol{margin:0;padding:0;list-style:none}\n.msq-toc li{display:flex;gap:10px;align-items:center;padding:6px 6px;border-bottom:1px solid #DDD0DF;border-radius:8px}\n.msq-toc li:last-child{border-bottom:0}.msq-toc li.is-active{background:#fff}\n.msq-toc-play{flex:0 0 auto;width:30px;height:30px;border-radius:50%;border:0;background:#5E3870;color:#fff;font:inherit;font-size:.72em;line-height:30px;padding:0;cursor:pointer}\n.msq-toc-play.is-playing{background:#B85F33}\n.msq-toc-time{flex:0 0 auto;min-width:3.1em;font-variant-numeric:tabular-nums;color:#544C5E;font-size:.9em}\n.msq-toc a{color:#1B1F24;text-decoration:none;line-height:1.35}.msq-toc li.is-active a{font-weight:700;color:#5E3870}\n.msq-audio-note{margin:10px 0 0;font-size:.82em;color:#544C5E}\nh2.wp-block-heading[id]{scroll-margin-top:24px}\n.msq-hplay{display:inline-block;vertical-align:middle;width:26px;height:26px;margin:0 0 0 10px;border-radius:50%;border:0;background:#5E3870;cursor:pointer;padding:0;position:relative;top:-2px}\n.msq-hplay::before{content:'\u25b6\ufe0e';display:block;color:#fff;font-size:11px;line-height:26px;text-align:center}\n.msq-hplay.is-playing{background:#B85F33}.msq-hplay.is-playing::before{content:'\u2016';font-size:13px;font-weight:700}\n.msq-bar{position:fixed;left:0;right:0;bottom:0;z-index:9000;display:flex;align-items:center;gap:10px;padding:8px 12px;padding-bottom:calc(8px + env(safe-area-inset-bottom));background:#FFFFFF;border-top:1px solid #DDD0DF;box-shadow:0 -4px 16px rgba(0,0,0,.08);font-size:.92em;color:#1B1F24;transition:transform .2s ease}\n.msq-bar.is-hidden{transform:translateY(130%)}\n.msq-bar-play{display:inline-flex;align-items:center;gap:8px;border:0;border-radius:999px;background:#5E3870;color:#fff;font:inherit;font-weight:700;padding:8px 14px 8px 12px;cursor:pointer;white-space:nowrap}\n.msq-bar-play.is-playing{background:#B85F33}\n.msq-bar-icon::before{content:'\u25b6\ufe0e';font-size:12px}.msq-bar-play.is-playing .msq-bar-icon::before{content:'\u2016';font-size:14px;font-weight:700}\n.msq-bar-chapter{flex:1 1 auto;min-width:0;overflow:hidden;text-overflow:ellipsis;white-space:nowrap}\n.msq-bar-time{flex:0 0 auto;font-variant-numeric:tabular-nums;color:#544C5E;font-size:.9em}\n.msq-bar-rate,.msq-bar-close{flex:0 0 auto;border:1px solid #DDD0DF;background:#fff;color:#1B1F24;font:inherit;font-size:.85em;line-height:1;border-radius:8px;padding:7px 9px;cursor:pointer}\n.msq-bar-close::before{content:'\u2715'}\n.msq-bar.msq-bar-pill{left:auto;right:14px;bottom:14px;padding:6px;padding-bottom:6px;border:1px solid #DDD0DF;border-radius:999px;box-shadow:0 6px 20px rgba(0,0,0,.15)}\n.msq-bar.msq-bar-pill .msq-bar-chapter,.msq-bar.msq-bar-pill .msq-bar-time,.msq-bar.msq-bar-pill .msq-bar-rate{display:none}\nbody.msq-has-bar{padding-bottom:76px}\n@media (max-width:600px){.msq-bar-time{display:none}.msq-bar{gap:8px;padding-left:10px;padding-right:10px}}\n.msq-s.msq-now{background:#F5EFF5;box-shadow:0 2px 0 #5E3870;border-radius:2px}\ntr.msq-now td,tr.msq-now th{background:#F5EFF5;box-shadow:inset 0 -2px 0 #5E3870}\n@media (hover:hover){.msq-s,tr[data-i]{cursor:pointer}.msq-s:hover{background:#F5EFF5}}<\/style>\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"AudioObject\",\"@id\":\"https:\/\/pauseproof.com\/articles\/hormone-replacement-therapy-for-perimenopause\/#audio\",\"name\":\"Hormone Replacement Therapy for Perimenopause: NICE, Quoted, read aloud\",\"description\":\"Synthetic voice reading of the article, recorded 18 October 2026.\",\"contentUrl\":\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/10\/hormone-replacement-therapy-for-perimenopause-audio-202610181423.mp3\",\"encodingFormat\":\"audio\/mpeg\",\"duration\":\"PT14M57S\",\"uploadDate\":\"2026-10-18\",\"inLanguage\":\"en-GB\",\"isAccessibleForFree\":true,\"mainEntityOfPage\":\"https:\/\/pauseproof.com\/articles\/hormone-replacement-therapy-for-perimenopause\/\",\"hasPart\":[{\"@type\":\"Clip\",\"name\":\"Hormone Replacement Therapy for Perimenopause: NICE, Quoted\",\"startOffset\":0,\"endOffset\":56},{\"@type\":\"Clip\",\"name\":\"Can you have HRT while you are still having periods?\",\"startOffset\":56,\"endOffset\":151,\"url\":\"https:\/\/pauseproof.com\/articles\/hormone-replacement-therapy-for-perimenopause\/#can-you-have-hrt-while-you-are-still-having-periods\"},{\"@type\":\"Clip\",\"name\":\"Which symptoms does NICE say HRT is for, and which is it not for?\",\"startOffset\":151,\"endOffset\":326,\"url\":\"https:\/\/pauseproof.com\/articles\/hormone-replacement-therapy-for-perimenopause\/#which-symptoms-does-nice-say-hrt-is-for-and-which-is-it-not\"},{\"@type\":\"Clip\",\"name\":\"What forms of HRT exist, and what must the conversation cover?\",\"startOffset\":326,\"endOffset\":435,\"url\":\"https:\/\/pauseproof.com\/articles\/hormone-replacement-therapy-for-perimenopause\/#what-forms-of-hrt-exist-and-what-must-the-conversation-cover\"},{\"@type\":\"Clip\",\"name\":\"What are the risks of HRT, in NICE's own numbers?\",\"startOffset\":435,\"endOffset\":560,\"url\":\"https:\/\/pauseproof.com\/articles\/hormone-replacement-therapy-for-perimenopause\/#what-are-the-risks-of-hrt-in-nice-s-own-numbers\"},{\"@type\":\"Clip\",\"name\":\"Why do UK and US pages say different things about HRT?\",\"startOffset\":560,\"endOffset\":723,\"url\":\"https:\/\/pauseproof.com\/articles\/hormone-replacement-therapy-for-perimenopause\/#why-do-uk-and-us-pages-say-different-things-about-hrt\"},{\"@type\":\"Clip\",\"name\":\"What do women in their forties report when they ask about HRT?\",\"startOffset\":723,\"endOffset\":846,\"url\":\"https:\/\/pauseproof.com\/articles\/hormone-replacement-therapy-for-perimenopause\/#what-do-women-in-their-forties-report-when-they-ask-about-hr\"},{\"@type\":\"Clip\",\"name\":\"What has changed since this was first published?\",\"startOffset\":846,\"endOffset\":897,\"url\":\"https:\/\/pauseproof.com\/articles\/hormone-replacement-therapy-for-perimenopause\/#what-has-changed-since-this-was-first-published\"}],\"contentSize\":\"6.3 MB\"}<\/script>\n<p class=\"msq-audio-lead\"><strong>Listen to this article<\/strong>, about 15 minutes. A synthetic voice reads the article and announces each section title as it begins; tables are read row by row and the questions at the end are left out.<\/p>\n<audio class=\"msq-audio-player\" controls preload=\"metadata\" src=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/10\/hormone-replacement-therapy-for-perimenopause-audio-202610181423.mp3\"><\/audio>\n<nav class=\"msq-toc\" aria-label=\"In this article\"><p class=\"msq-toc-title\">In this article<\/p>\n<ol>\n<li data-start=\"0.0\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"0.0\" aria-label=\"Play from: Hormone Replacement Therapy for Perimenopause: NICE, Quoted\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">0:00<\/span><a href=\"#top\">Hormone Replacement Therapy for Perimenopause: NICE, Quoted<\/a><\/li>\n<li data-start=\"55.54\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"55.54\" aria-label=\"Play from: Can you have HRT while you are still having periods?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">0:56<\/span><a href=\"#can-you-have-hrt-while-you-are-still-having-periods\">Can you have HRT while you are still having periods?<\/a><\/li>\n<li data-start=\"150.96\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"150.96\" aria-label=\"Play from: Which symptoms does NICE say HRT is for, and which is it not for?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">2:31<\/span><a href=\"#which-symptoms-does-nice-say-hrt-is-for-and-which-is-it-not\">Which symptoms does NICE say HRT is for, and which is it not for?<\/a><\/li>\n<li data-start=\"325.74\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"325.74\" aria-label=\"Play from: What forms of HRT exist, and what must the conversation cover?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">5:26<\/span><a href=\"#what-forms-of-hrt-exist-and-what-must-the-conversation-cover\">What forms of HRT exist, and what must the conversation cover?<\/a><\/li>\n<li data-start=\"434.6\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"434.6\" aria-label=\"Play from: What are the risks of HRT, in NICE&#x27;s own numbers?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">7:15<\/span><a href=\"#what-are-the-risks-of-hrt-in-nice-s-own-numbers\">What are the risks of HRT, in NICE&#x27;s own numbers?<\/a><\/li>\n<li data-start=\"560.06\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"560.06\" aria-label=\"Play from: Why do UK and US pages say different things about HRT?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">9:20<\/span><a href=\"#why-do-uk-and-us-pages-say-different-things-about-hrt\">Why do UK and US pages say different things about HRT?<\/a><\/li>\n<li data-start=\"722.68\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"722.68\" aria-label=\"Play from: What do women in their forties report when they ask about HRT?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">12:03<\/span><a href=\"#what-do-women-in-their-forties-report-when-they-ask-about-hr\">What do women in their forties report when they ask about HRT?<\/a><\/li>\n<li data-start=\"846.5\"><button type=\"button\" class=\"msq-toc-play\" data-start=\"846.5\" aria-label=\"Play from: What has changed since this was first published?\">&#x25B6;&#xFE0E;<\/button><span class=\"msq-toc-time\">14:06<\/span><a href=\"#what-has-changed-since-this-was-first-published\">What has changed since this was first published?<\/a><\/li>\n<\/ol><\/nav>\n<p class=\"msq-audio-note\">Recorded 18 October 2026 from the article as published that day. Press a chapter to jump there; the highlighted line is what is playing. A play button sits beside every section heading, and once you scroll past this player a bar at the bottom of the screen keeps the controls in reach. Tap or click any sentence to hear the reading start from there.<\/p>\n<script>var MSQ_SENT = [[0.0,\"h\",\"hormonereplacementtherap\",51],[3.6,\"p\",\"hormonereplacementtherap\",129],[11.68,\"p\",\"nicesaystoofferhrtforhot\",155],[22.0,\"p\",\"onthispageniceng23quoted\",155],[35.04,\"p\",\"thispagequotestheguideli\",104],[43.16,\"p\",\"itdoesnotsaywhetherhrtsu\",56],[48.24,\"p\",\"thosebelongtoyouandaclin\",96],[55.54,\"h\",\"canyouhavehrtwhileyouare\",42],[58.42,\"p\",\"nothingintheguidelinesay\",34],[60.5,\"p\",\"niceguidelineng23lastupd\",115],[72.14,\"p\",\"recommendation131identif\",179],[86.26,\"p\",\"changingperiodsarepartof\",53],[89.86,\"p\",\"thehrtrecommendationsthe\",101],[96.54,\"p\",\"recommendation181saystoo\",136],[107.66,\"p\",\"section14coverseveryonea\",177],[124.02,\"p\",\"ifyouweretoldyouaretooyo\",81],[129.3,\"p\",\"onepracticalpointmatters\",54],[132.78,\"p\",\"thenhspageonhrtsaysitiss\",150],[145.34,\"p\",\"hrtisnotcontraception\",21],[147.58,\"p\",\"wecoverthedetailinwhenco\",42],[150.96,\"h\",\"whichsymptomsdoesnicesay\",50],[155.32,\"p\",\"nicechoosesitsverbscaref\",28],[157.28,\"p\",\"offermeansthecommitteewa\",99],[164.04,\"p\",\"hereishowtheguidelinewor\",104],[171.0,\"t\",\"hotflushesandnightsweats\",61],[178.96,\"t\",\"vaginaldrynesspainwithse\",121],[192.6,\"t\",\"depressivesymptomsthatdo\",128],[204.44,\"t\",\"diagnoseddepression\",92],[215.32,\"t\",\"sleepproblemslinkedtonig\",125],[228.8,\"t\",\"lowsexualdesire\",89],[239.32,\"t\",\"fragilityfracture\",97],[248.72,\"t\",\"musclemassandstrength\",78],[257.52,\"t\",\"preventingheartdisease\",71],[265.96,\"t\",\"preventingdementia\",67],[274.52,\"p\",\"twolinesinthattablegetlo\",36],[276.92,\"p\",\"hrtisforsymptomsniceisex\",93],[285.52,\"p\",\"andforhotflushesalonerec\",113],[296.12,\"p\",\"recommendation145addstha\",169],[308.88,\"p\",\"welookedatthenonprescrip\",84],[313.28,\"p\",\"thelowdesirerowistheonen\",76],[318.28,\"p\",\"ourpageonwhattheresearch\",110],[325.74,\"h\",\"whatformsofhrtexistandwh\",50],[329.9,\"p\",\"systemichrtthekindabsorb\",134],[340.74,\"p\",\"theprogestogenthatprotec\",81],[346.18,\"p\",\"vaginaloestrogenissepara\",148],[359.18,\"p\",\"whatthosegenitourinarysy\",137],[367.78,\"p\",\"recommendation142listswh\",211],[384.42,\"p\",\"143saystodiscusshowlongt\",137],[395.5,\"p\",\"183saystousethelowesteff\",36],[399.06,\"p\",\"192setsreviewsat3monthsa\",39],[404.18,\"p\",\"1528saystoconsiderhrtthr\",114],[413.86,\"p\",\"bleedingistheparttoknowi\",45],[416.78,\"p\",\"recommendation184amended\",180],[431.7,\"p\",\"bleedingaftermenopauseha\",35],[434.6,\"h\",\"whataretherisksofhrtinni\",37],[438.6,\"p\",\"nicepublishesanhrtdiscus\",89],[445.32,\"p\",\"itsmainestimatesareforwo\",96],[453.8,\"p\",\"thebreastcancerfiguresco\",63],[458.76,\"t\",\"breastcancerages50to69\",83],[470.44,\"t\",\"fragilityfractureages50t\",74],[479.2,\"t\",\"fragilityfractureages50t\",76],[489.92,\"t\",\"endometrialcancerages50t\",97],[501.68,\"t\",\"strokeages50to54\",78],[509.52,\"t\",\"breastcancerearlymenopau\",88],[520.52,\"p\",\"aroundthosenumbersthegui\",49],[523.44,\"p\",\"overallcombinedoroestrog\",68],[530.92,\"p\",\"breastcancerriskwithcomb\",116],[539.88,\"p\",\"bloodclotriskisraisedwit\",62],[544.56,\"p\",\"thesearepopulationfigure\",165],[560.06,\"h\",\"whydoukanduspagessaydiff\",43],[564.14,\"p\",\"becausetheyareworkingfro\",74],[568.78,\"p\",\"theuspagesthatrankforthi\",82],[573.74,\"p\",\"hereiswhateachsourcesays\",29],[575.74,\"t\",\"niceng23updated15april20\",162],[593.58,\"t\",\"themenopausesocietythenn\",198],[610.46,\"t\",\"usfdaannounced10november\",133],[623.74,\"t\",\"officeonwomenshealthpage\",155],[639.46,\"t\",\"nhspagelastreviewed7febr\",114],[651.54,\"p\",\"onerowinthattableneedsas\",41],[654.46,\"p\",\"thenovember2025announcem\",66],[659.42,\"p\",\"on12february2026thefdaap\",249],[679.38,\"p\",\"sowhetheraparticularuspr\",96],[685.3,\"p\",\"thatisaquestionforthepre\",76],[689.82,\"p\",\"thereisoneoutrightcontra\",31],[691.86,\"p\",\"thefdaannouncementsayswo\",136],[702.22,\"p\",\"nicerecommendation161say\",67],[708.5,\"p\",\"bothcannotbethewholepict\",70],[713.78,\"p\",\"theshortesttimewordingme\",94],[722.68,\"h\",\"whatdowomenintheirfortie\",50],[726.72,\"p\",\"toseehowtheguidancemeets\",138],[738.32,\"p\",\"wereadthefirsttwoofitsth\",44],[741.64,\"p\",\"apollonthethreaddrew191v\",69],[748.56,\"p\",\"whatfollowsiswhatposters\",52],[752.64,\"p\",\"theopeningpostersaidshew\",97],[759.28,\"p\",\"onereplydescribedanolder\",124],[768.0,\"p\",\"anothersaidittooknearlyt\",96],[774.52,\"p\",\"aposterwhohadahysterecto\",113],[783.2,\"p\",\"severalpostscuttheotherw\",52],[786.56,\"p\",\"onesaidfibroidsandotherc\",65],[790.72,\"p\",\"oneposterreportedthather\",67],[795.0,\"p\",\"anotherpassedonagpfriend\",77],[800.12,\"p\",\"onbloodteststhethreadspl\",85],[806.48,\"p\",\"againsttheguidelinethepa\",36],[808.92,\"p\",\"theideathatperiodsmustst\",79],[816.64,\"p\",\"butat43recommendation136\",121],[827.96,\"p\",\"whyanormalhormoneresults\",52],[831.44,\"p\",\"whethertheantidepressant\",123],[840.64,\"p\",\"ifmoodisthemainthingourp\",80],[846.5,\"h\",\"whathaschangedsincethisw\",40],[848.66,\"p\",\"addedinoctober2026thefda\",85],[856.86,\"p\",\"thefirstapprovedlabelcha\",125],[867.1,\"p\",\"thispagepreviouslyreadas\",59],[871.42,\"p\",\"notrecheckedon18october2\",61],[879.62,\"p\",\"thenicesiterefusedouraut\",86],[886.74,\"p\",\"thisarticleisgeneralinfo\",109],[893.5,\"p\",\"speaktoyourdoctoraboutyo\",38]];\n(function(){\n  function init(){\n  var root = document.querySelector('.msq-audio'); if (!root) { return; }\n  var audio = root.querySelector('audio'), items = Array.prototype.slice.call(root.querySelectorAll('.msq-toc li'));\n  var starts = items.map(function(li){ return parseFloat(li.getAttribute('data-start')) || 0; });\n  var names = items.map(function(li){ return li.querySelector('a').textContent; });\n  var anchors = items.map(function(li){ var h = li.querySelector('a').getAttribute('href') || ''; return (h.charAt(0) === '#' && h !== '#top') ? document.getElementById(h.slice(1)) : null; });\n  var article = root.getAttribute('data-article') || location.pathname, minutes = root.getAttribute('data-minutes') || '';\n  var marks = {}, started = false, pausedAt = -1, closed = false, ended = false;\n  var RATES = [1, 1.25, 1.5], rate = 1;\n  try { var saved = parseFloat(localStorage.getItem('msq-audio-rate')); if (RATES.indexOf(saved) >= 0) { rate = saved; } } catch (e) {}\n  audio.playbackRate = rate;\n  function track(name, extra){ try { if (typeof gtag === 'function') { var p = { article: article }; for (var k in extra) { p[k] = extra[k]; } gtag('event', name, p); } } catch (e) {} }\n  function current(){ var t = audio.currentTime, idx = 0; for (var i = 0; starts.length > i; i += 1) { if (t + 0.25 >= starts[i]) { idx = i; } } return idx; }\n  function onScreen(){\n    var line = window.innerHeight \/ 3, idx = 0;\n    for (var i = 0; anchors.length > i; i += 1) { var el = anchors[i]; if (el && line >= el.getBoundingClientRect().top) { idx = i; } }\n    return idx;\n  }\n  function fmt(s){ s = Math.max(0, Math.round(s || 0)); var m = Math.floor(s \/ 60), r = s % 60; return m + ':' + (10 > r ? '0' : '') + r; }\n  function play(from, source){\n    if (from !== null) { audio.currentTime = from; }\n    var p = audio.play(); if (p && p.catch) { p.catch(function(){}); }\n    track(from === null ? 'audio_resume' : 'audio_chapter', { chapter: names[current()], start: Math.round(audio.currentTime), source: source });\n  }\n  var hbtns = anchors.map(function(el, i){\n    if (!el) { return null; }\n    var b = document.createElement('button'); b.type = 'button'; b.className = 'msq-hplay'; b.setAttribute('aria-label', 'Play this section: ' + names[i]);\n    b.addEventListener('click', function(){\n      if (!audio.paused && current() === i) { audio.pause(); track('audio_pause', { source: 'heading' }); return; }\n      play(starts[i], 'heading');\n    });\n    el.appendChild(b); return b;\n  });\n  var bar = document.createElement('div'); bar.className = 'msq-bar msq-bar-pill is-hidden'; bar.setAttribute('role', 'region'); bar.setAttribute('aria-label', 'Audio player');\n  var playBtn = document.createElement('button'); playBtn.type = 'button'; playBtn.className = 'msq-bar-play';\n  var icon = document.createElement('span'); icon.className = 'msq-bar-icon'; icon.setAttribute('aria-hidden', 'true');\n  var label = document.createElement('span'); label.className = 'msq-bar-label';\n  playBtn.appendChild(icon); playBtn.appendChild(label);\n  var chap = document.createElement('span'); chap.className = 'msq-bar-chapter';\n  var clock = document.createElement('span'); clock.className = 'msq-bar-time';\n  var rateBtn = document.createElement('button'); rateBtn.type = 'button'; rateBtn.className = 'msq-bar-rate'; rateBtn.setAttribute('aria-label', 'Playback speed');\n  var closeBtn = document.createElement('button'); closeBtn.type = 'button'; closeBtn.className = 'msq-bar-close'; closeBtn.setAttribute('aria-label', 'Close the audio bar');\n  bar.appendChild(playBtn); bar.appendChild(chap); bar.appendChild(clock); bar.appendChild(rateBtn); bar.appendChild(closeBtn);\n  document.body.appendChild(bar);\n  function showRate(){ rateBtn.textContent = (rate === 1 ? '1' : String(rate)) + 'x'; }\n  showRate();\n  rateBtn.addEventListener('click', function(){\n    rate = RATES[(RATES.indexOf(rate) + 1) % RATES.length]; audio.playbackRate = rate; showRate();\n    try { localStorage.setItem('msq-audio-rate', String(rate)); } catch (e) {}\n    track('audio_rate', { rate: rate });\n  });\n  closeBtn.addEventListener('click', function(){\n    closed = true; if (!audio.paused) { audio.pause(); } paint(); track('audio_bar_close', {});\n  });\n  function mode(){\n    if (!audio.paused) { return 'pause'; }\n    if (ended) { return 'again'; }\n    if (!started) { return 'listen'; }\n    return (pausedAt === onScreen()) ? 'resume' : 'section';\n  }\n  playBtn.addEventListener('click', function(){\n    var m = mode();\n    if (m === 'pause') { audio.pause(); track('audio_pause', { source: 'bar' }); return; }\n    if (m === 'again') { ended = false; play(0, 'bar'); return; }\n    if (m === 'resume') { play(null, 'bar'); return; }\n    play(starts[onScreen()], 'bar');\n  });\n  function paint(){\n    var idx = current(), playing = !audio.paused, m = mode();\n    items.forEach(function(li, i){\n      var on = (i === idx) && playing, b = li.querySelector('.msq-toc-play'), a = li.querySelector('a');\n      li.classList.toggle('is-active', on); b.classList.toggle('is-playing', on);\n      b.textContent = on ? '\u2016' : '\u25b6\ufe0e';\n      b.setAttribute('aria-label', (on ? 'Pause: ' : 'Play from: ') + a.textContent);\n    });\n    hbtns.forEach(function(b, i){ if (b) { var on = (i === idx) && playing; b.classList.toggle('is-playing', on); b.setAttribute('aria-label', (on ? 'Pause this section: ' : 'Play this section: ') + names[i]); } });\n    playBtn.classList.toggle('is-playing', playing);\n    label.textContent = m === 'pause' ? 'Pause' : m === 'again' ? 'Play again' : m === 'resume' ? 'Resume' : m === 'section' ? 'Play this section' : 'Listen, ' + minutes + ' min';\n    playBtn.setAttribute('aria-label', label.textContent);\n    chap.textContent = started ? names[(playing || m === 'resume') ? idx : onScreen()] : '';\n    clock.textContent = started ? fmt(audio.currentTime) + ' \/ ' + fmt(audio.duration) : '';\n    bar.classList.toggle('msq-bar-pill', !started);\n    var show = !closed && (started || 0 > root.getBoundingClientRect().bottom);\n    bar.classList.toggle('is-hidden', !show);\n    document.body.classList.toggle('msq-has-bar', show);\n  }\n  root.addEventListener('click', function(e){\n    var b = e.target.closest ? e.target.closest('.msq-toc-play') : null; if (!b) { return; }\n    var li = b.parentNode, s = parseFloat(b.getAttribute('data-start')) || 0;\n    if (!audio.paused && current() === items.indexOf(li)) { audio.pause(); track('audio_pause', { source: 'index' }); return; }\n    play(s, 'index');\n  });\n  audio.addEventListener('play', function(){ ended = false; closed = false; if (!started) { started = true; track('audio_play', { minutes: Math.round((audio.duration || 0) \/ 60) }); } paint(); });\n  audio.addEventListener('pause', function(){ pausedAt = current(); paint(); });\n  audio.addEventListener('timeupdate', function(){\n    paint();\n    if (audio.duration > 0) {\n      var pct = Math.floor(audio.currentTime \/ audio.duration * 100);\n      [25, 50, 75].forEach(function(m){ if (pct >= m && !marks[m]) { marks[m] = true; track('audio_progress', { percent: m }); } });\n    }\n  });\n  audio.addEventListener('ended', function(){ ended = true; track('audio_complete', {}); paint(); });\n  var ticking = false;\n  function onScroll(){ if (ticking) { return; } ticking = true; setTimeout(function(){ ticking = false; paint(); }, 80); }\n  window.addEventListener('scroll', onScroll, { passive: true }); window.addEventListener('resize', onScroll);\n  paint();\n  }\n  if (document.readyState === 'loading') { document.addEventListener('DOMContentLoaded', init); } else { init(); }\n})();\n\n(function(){\n  function start(){\n    var root = document.querySelector('.msq-audio'), audio = root ? root.querySelector('audio') : null;\n    var map = (typeof MSQ_SENT !== 'undefined') ? MSQ_SENT : [];\n    if (!root || !audio || !map.length) { return; }\n    var scope = root.closest('main') || root.closest('article') || root.closest('.entry-content') || document.body;\n    var SKIP = '.msq-audio,.msq,.msq-tool,.msq-end,.msq-bar,script,style,noscript,figcaption,#rank-math-faq,.rank-math-block,nav,header,footer';\n    function norm(s){ return s.toLowerCase().replace(\/[^a-z0-9]+\/g, ''); }\n    var nodes = [], stream = '', walker = document.createTreeWalker(scope, NodeFilter.SHOW_TEXT, null), n;\n    while ((n = walker.nextNode())) {\n      var el = n.parentElement; if (!el || el.closest(SKIP)) { continue; }\n      var raw = n.nodeValue, keep = [], norms = '';\n      for (var i = 0; raw.length > i; i += 1) { var c = raw.charAt(i).toLowerCase(); if (\/[a-z0-9]\/.test(c)) { keep.push(i); norms += c; } }\n      if (!norms) { continue; }\n      nodes.push({ node: n, a: stream.length, b: stream.length + norms.length, keep: keep });\n      stream += norms;\n    }\n    var segs = [], cursor = 0, lastRow = null;\n    map.forEach(function(m, idx){\n      var kind = m[1], f = m[2], len = m[3];\n      if (kind === 't') {\n        var rows = scope.querySelectorAll('tr'), after = !lastRow;\n        for (var r = 0; rows.length > r; r += 1) {\n          var tr = rows[r];\n          if (!after) { if (tr === lastRow) { after = true; } continue; }\n          var cell = tr.querySelector('td,th');\n          if (cell && norm(cell.textContent).indexOf(f) === 0) { tr.setAttribute('data-i', idx); lastRow = tr; break; }\n        }\n        return;\n      }\n      var p = stream.indexOf(f, cursor); if (0 > p) { return; }\n      segs.push({ i: idx, a: p, b: Math.min(p + len, stream.length) }); cursor = p + len;\n    });\n    var si = 0;\n    nodes.forEach(function(nd){\n      var frag = document.createDocumentFragment(), raw = nd.node.nodeValue, rawPos = 0, any = false;\n      for (var k = si; segs.length > k; k += 1) {\n        var sg = segs[k]; if (sg.a >= nd.b) { break; } if (nd.a >= sg.b) { continue; }\n        var s = Math.max(sg.a, nd.a), e = Math.min(sg.b, nd.b);\n        var rs = nd.keep[s - nd.a], re2 = nd.keep[e - nd.a - 1] + 1;\n        if (rs > rawPos) { frag.appendChild(document.createTextNode(raw.slice(rawPos, rs))); }\n        var span = document.createElement('span'); span.className = 'msq-s'; span.setAttribute('data-i', sg.i); span.textContent = raw.slice(rs, re2);\n        frag.appendChild(span); rawPos = re2; any = true;\n        if (sg.b > nd.b) { break; }\n      }\n      while (segs.length > si && nd.b >= segs[si].b) { si += 1; }\n      if (!any) { return; }\n      if (raw.length > rawPos) { frag.appendChild(document.createTextNode(raw.slice(rawPos))); }\n      nd.node.parentNode.replaceChild(frag, nd.node);\n    });\n    var starts = map.map(function(m){ return m[0]; }), curIdx = -1, lastUser = 0, timer = null, autoUntil = 0, dragging = false;\n    function idxAt(t){ var lo = 0, hi = starts.length; while (hi > lo + 1) { var mid = (lo + hi) >> 1; if (t + 0.15 >= starts[mid]) { lo = mid; } else { hi = mid; } } return (t + 0.15 >= starts[0]) ? lo : -1; }\n    function setNow(i){\n      if (i === curIdx) { return; }\n      Array.prototype.forEach.call(scope.querySelectorAll('.msq-now'), function(el){ el.classList.remove('msq-now'); });\n      curIdx = i; if (0 > i) { return; }\n      var els = scope.querySelectorAll('[data-i=\"' + i + '\"]'); if (!els.length) { return; }\n      Array.prototype.forEach.call(els, function(el){ el.classList.add('msq-now'); });\n      var r = els[0].getBoundingClientRect(), now = Date.now();\n      if (!dragging && now > lastUser + 2500 && (80 > r.top || r.bottom > window.innerHeight - 140)) {\n        var reduce = window.matchMedia && window.matchMedia('(prefers-reduced-motion: reduce)').matches;\n        autoUntil = now + (reduce ? 400 : 1600);\n        els[0].scrollIntoView({ block: 'center', behavior: reduce ? 'auto' : 'smooth' });\n      }\n    }\n    function tick(){ if (!audio.paused) { setNow(idxAt(audio.currentTime)); } }\n    function userScrolled(){ lastUser = Date.now(); }\n    ['wheel', 'touchmove', 'keydown'].forEach(function(ev){ window.addEventListener(ev, userScrolled, { passive: true }); });\n    window.addEventListener('scroll', function(){ if (Date.now() > autoUntil) { userScrolled(); } }, { passive: true });\n    window.addEventListener('mousedown', function(e){ if (e.clientX >= document.documentElement.clientWidth) { dragging = true; userScrolled(); } }, { passive: true });\n    window.addEventListener('mouseup', function(){ if (dragging) { dragging = false; userScrolled(); } }, { passive: true });\n    audio.addEventListener('play', function(){ if (timer) { clearInterval(timer); } timer = setInterval(tick, 150); tick(); });\n    audio.addEventListener('pause', function(){ if (timer) { clearInterval(timer); timer = null; } });\n    scope.addEventListener('click', function(e){\n      if (e.target.closest('a, button, input, select, textarea, label, summary, .msq, .msq-tool, .msq-end, .msq-audio, .msq-bar')) { return; }\n      var sel = window.getSelection ? String(window.getSelection()) : '';\n      if (sel && sel.trim()) { return; }\n      var el = e.target.closest('[data-i]'); if (!el) { return; }\n      var i = parseInt(el.getAttribute('data-i'), 10); if (isNaN(i)) { return; }\n      if (!audio.paused && i === curIdx) { return; }\n      lastUser = Date.now();\n      audio.currentTime = starts[i];\n      var p = audio.play(); if (p && p.catch) { p.catch(function(){}); }\n      try { if (typeof gtag === 'function') { gtag('event', 'audio_chapter', { article: location.pathname, source: 'sentence', start: Math.round(starts[i]) }); } } catch (err) {}\n    });\n    audio.addEventListener('seeked', tick);\n    audio.addEventListener('ended', function(){ setNow(-1); });\n  }\n  if (document.readyState === 'loading') { document.addEventListener('DOMContentLoaded', start); } else { start(); }\n})();<\/script>\n<\/div>\n\n\n\n<p class=\"msq-hook wp-block-paragraph\">On this page: NICE NG23 quoted recommendation by recommendation, what HRT is for and is not for, the risks in NICE&#8217;s own numbers, and the appointment checklist built from the guideline itself.<\/p>\n\n\n\n<div class=\"msq\" id=\"ms-quiz\" data-slug=\"hormone-replacement-therapy-for-perimenopause\" data-category=\"perimenopause and menopause\" data-list=\"1\">\n<style>.msq,.msq-hook,.msq-box,.msq-end,.msq-tool{--msq-accent:#5E3870;--msq-accent-text:#FFFFFF;--msq-line:#DDD0DF;--msq-warn:#B85F33;--msq-muted:#544C5E;--msq-tint:#F5EFF5;--msq-base:#FFFFFF}\n.msq{margin:1.25em 0 1.75em}\n.msq-hook{border-left:3px solid var(--msq-accent);padding:6px 14px;color:var(--msq-muted);font-size:.97em}\n.msq-box{background:var(--msq-tint);border:1px solid var(--msq-line);border-radius:12px;padding:0}\n.msq-box>summary{cursor:pointer;list-style:none;padding:14px 18px;font-weight:700;color:var(--msq-accent)}\n.msq-box>summary::-webkit-details-marker{display:none}\n.msq-box>summary::before{content:\"+\";display:inline-block;width:1.1em;font-weight:800}\n.msq-box[open]>summary::before{content:\"\\00d7\"}\n.msq-body{padding:2px 18px 18px}\n.msq-intro{margin:0 0 12px;font-size:.95em;color:var(--msq-muted)}\n.msq-list{margin:0;padding:0;list-style:none}\n.msq-q{margin:0 0 18px;padding:0}\n.msq-question{font-weight:700;margin:0 0 8px}\n.msq-options{display:flex;flex-direction:column;gap:8px}\n.msq-opt{text-align:left;background:var(--msq-base);border:1px solid var(--msq-line);border-radius:8px;padding:10px 12px;font:inherit;font-size:.95em;color:inherit;cursor:pointer;line-height:1.35}\n.msq-opt:hover{border-color:var(--msq-accent)}\n.msq-opt[disabled]{cursor:default}\n.msq-opt.is-right{border-color:var(--msq-accent);background:var(--msq-line);font-weight:700}\n.msq-opt.is-wrong{border-color:var(--msq-warn);color:var(--msq-warn)}\n.msq-explain{margin:8px 0 0;font-size:.92em;padding:10px 12px;border-left:3px solid var(--msq-accent);background:var(--msq-base);border-radius:0 8px 8px 0}\n.msq-explain[hidden]{display:none}\n.msq-verdict{font-weight:700}\n.msq-result{margin-top:14px;padding:14px 16px;background:var(--msq-base);border:1px solid var(--msq-line);border-radius:10px}\n.msq-result[hidden]{display:none}\n.msq-result h3{margin:0 0 6px;font-size:1.1em}\n.msq-result p{margin:0 0 8px}\n.msq-jump{margin:0 0 8px;padding-left:1.2em}\n.msq-form{margin-top:10px;display:flex;flex-wrap:wrap;gap:8px;align-items:center}\n.msq-form input[type=email]{flex:1 1 220px;padding:10px 12px;border:1px solid var(--msq-muted);border-radius:8px;font:inherit;background:#fff}\n.msq-btn{background:var(--msq-accent);color:var(--msq-accent-text);border:0;border-radius:8px;padding:11px 18px;font:inherit;font-weight:700;cursor:pointer}\n.msq-btn:hover{filter:brightness(.92)}\n.msq-btn[disabled]{opacity:.7;cursor:default}\n.msq-no{font-size:.9em;color:var(--msq-muted);margin-left:4px}\n.msq-privacy{margin:6px 0 0;font-size:.82em;color:var(--msq-muted);flex-basis:100%}\n.msq-hp{position:absolute;left:-5000px;width:1px;height:1px;overflow:hidden}\n.msq-msg{margin:8px 0 0;font-size:.92em}\n.msq-end{margin:1.5em 0;padding:18px;border:1px solid var(--msq-accent);border-radius:12px;text-align:center;background:var(--msq-tint)}\n.msq-end p{margin:0 0 12px}\n.msq-end .msq-body{text-align:left;padding:16px 0 0}\n.msq-end .msq-start-test[hidden]{display:none}\n.msq-tool{margin:1.5em 0;padding:18px 20px;background:var(--msq-tint);border:1px solid var(--msq-line);border-radius:12px}\n.msq-tool h3{margin:0 0 6px;font-size:1.15em}\n.msq-tool p{margin:0 0 10px}\n.msq-tool .msq-note{font-size:.85em;color:var(--msq-muted);margin:10px 0 0}\n.msq-check label{display:flex;gap:10px;align-items:flex-start;padding:9px 0;border-bottom:1px solid var(--msq-line);cursor:pointer;line-height:1.4}\n.msq-check label:last-of-type{border-bottom:0}\n.msq-check input{margin-top:5px;flex:0 0 auto;width:18px;height:18px;accent-color:var(--msq-accent)}\n.msq-check-count{font-weight:700;margin:10px 0 0}\n.msq-verdict-box{margin:12px 0 0;padding:10px 14px;border-radius:8px;background:var(--msq-base);border-left:3px solid var(--msq-warn)}\n.msq-verdict-box[hidden]{display:none}\n.msq-calc{display:grid;grid-template-columns:1fr 1fr;gap:10px 16px}\n.msq-calc label{display:flex;flex-direction:column;gap:4px;font-size:.92em}\n.msq-calc input,.msq-calc select{padding:8px 10px;border:1px solid var(--msq-muted);border-radius:8px;font:inherit;background:#fff}\n.msq-calc-out{grid-column:1 \/ -1;margin-top:6px;padding:12px 14px;background:var(--msq-base);border-radius:8px;border:1px solid var(--msq-line)}\n.msq-calc-out strong{font-size:1.15em}\n.msq-choose label{display:block;padding:9px 12px;margin:0 0 8px;background:var(--msq-base);border:1px solid var(--msq-line);border-radius:8px;cursor:pointer}\n.msq-choose input{margin-right:8px;accent-color:var(--msq-accent)}\n.msq-choice-result{margin-top:10px;padding:12px 14px;background:var(--msq-base);border-left:3px solid var(--msq-accent);border-radius:0 8px 8px 0}\n.msq-choice-result[hidden]{display:none}\n@media (max-width:600px){.msq-calc{grid-template-columns:1fr}}\nh2.wp-block-heading[id]{scroll-margin-top:24px}<\/style>\n<noscript><style>.msq-explain{display:block !important}<\/style><\/noscript>\n<details class=\"msq-box\">\n<summary>Think you already know this? Five questions, one minute.<\/summary>\n<div class=\"msq-body\">\n<p class=\"msq-intro\">Every answer is on this page. Answer from what you know now; the page fills in the rest.<\/p>\n<ol class=\"msq-list\">\n<li class=\"msq-q\" data-q=\"1\" data-answer=\"b\" data-title=\"Can you have HRT while you are still having periods?\" data-section=\"#can-you-have-hrt-while-you-are-still-having-periods\">\n<p class=\"msq-question\">1. What does NICE recommendation 1.3.1 say about identifying perimenopause in someone aged 45 or over?<\/p>\n<div class=\"msq-options\" role=\"group\" aria-label=\"Question 1 options\"><button type=\"button\" class=\"msq-opt\" data-opt=\"a\">It requires a blood hormone test before anything else happens<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"b\">It can be identified from vasomotor symptoms and changing cycles, without laboratory tests<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"c\">It cannot be identified until periods have stopped completely<\/button><\/div>\n<p class=\"msq-explain\" hidden><span class=\"msq-verdict\"><\/span>NICE 1.3.1 identifies perimenopause without laboratory tests in otherwise healthy people 45 or over who have recent vasomotor symptoms and changes to their cycle. <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng23\/chapter\/Recommendations\" target=\"_blank\" rel=\"noopener\">NICE NG23<\/a> <a class=\"msq-section\" href=\"#can-you-have-hrt-while-you-are-still-having-periods\">Read the section<\/a><\/p>\n<\/li>\n<li class=\"msq-q\" data-q=\"2\" data-answer=\"b\" data-title=\"Which symptoms does NICE say HRT is for, and which is it not for?\" data-section=\"#which-symptoms-does-nice-say-hrt-is-for-and-which-is-it-not\">\n<p class=\"msq-question\">2. Which of these does NICE list as a reason not to start HRT?<\/p>\n<div class=\"msq-options\" role=\"group\" aria-label=\"Question 2 options\"><button type=\"button\" class=\"msq-opt\" data-opt=\"a\">Hot flushes and night sweats<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"b\">Preventing cardiovascular disease or dementia<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"c\">Depressive symptoms arriving alongside other menopause symptoms<\/button><\/div>\n<p class=\"msq-explain\" hidden><span class=\"msq-verdict\"><\/span>Recommendations 1.6.4 and 1.6.5 say not to offer HRT for primary or secondary prevention of cardiovascular disease or for dementia prevention; the licensed indication is symptoms. <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng23\/chapter\/Recommendations\" target=\"_blank\" rel=\"noopener\">NICE NG23<\/a> <a class=\"msq-section\" href=\"#which-symptoms-does-nice-say-hrt-is-for-and-which-is-it-not\">Read the section<\/a><\/p>\n<\/li>\n<li class=\"msq-q\" data-q=\"3\" data-answer=\"b\" data-title=\"What forms of HRT exist, and what must the conversation cover?\" data-section=\"#what-forms-of-hrt-exist-and-what-must-the-conversation-cover\">\n<p class=\"msq-question\">3. According to NICE recommendation 1.4.2, what should a clinician discuss before someone starts HRT?<\/p>\n<div class=\"msq-options\" role=\"group\" aria-label=\"Question 3 options\"><button type=\"button\" class=\"msq-opt\" data-opt=\"a\">Nothing beyond which brand is in stock that week<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"b\">Combined versus oestrogen-only, patch versus tablet, hormone types, and dose and duration<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"c\">Only whether the person wants a patch or a tablet<\/button><\/div>\n<p class=\"msq-explain\" hidden><span class=\"msq-verdict\"><\/span>1.4.2 lists combined versus oestrogen-only HRT, transdermal versus oral, types of oestrogen and progestogen, sequential versus continuous combined, and dose and duration as discussion points. <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng23\/chapter\/Recommendations\" target=\"_blank\" rel=\"noopener\">NICE NG23<\/a> <a class=\"msq-section\" href=\"#what-forms-of-hrt-exist-and-what-must-the-conversation-cover\">Read the section<\/a><\/p>\n<\/li>\n<li class=\"msq-q\" data-q=\"4\" data-answer=\"b\" data-title=\"What are the risks of HRT, in NICE&#x27;s own numbers?\" data-section=\"#what-are-the-risks-of-hrt-in-nice-s-own-numbers\">\n<p class=\"msq-question\">4. In NICE&#8217;s discussion aid, how does breast cancer risk behave with continued use of combined HRT?<\/p>\n<div class=\"msq-options\" role=\"group\" aria-label=\"Question 4 options\"><button type=\"button\" class=\"msq-opt\" data-opt=\"a\">It falls the longer someone stays on treatment<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"b\">It rises with duration of use and persists for at least 10 years after stopping<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"c\">It disappears the moment treatment stops<\/button><\/div>\n<p class=\"msq-explain\" hidden><span class=\"msq-verdict\"><\/span>NICE&#8217;s discussion aid states breast cancer risk with combined HRT rises with duration, is higher in current than past users, and persists at least 10 years after stopping. <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng23\/resources\/incidence-of-medical-conditions-with-and-without-hrt-a-discussion-aid-pdf-13553199901\" target=\"_blank\" rel=\"noopener\">NICE HRT discussion aid<\/a> <a class=\"msq-section\" href=\"#what-are-the-risks-of-hrt-in-nice-s-own-numbers\">Read the section<\/a><\/p>\n<\/li>\n<li class=\"msq-q\" data-q=\"5\" data-answer=\"a\" data-title=\"Why do UK and US pages say different things about HRT?\" data-section=\"#why-do-uk-and-us-pages-say-different-things-about-hrt\">\n<p class=\"msq-question\">5. What does The Menopause Society&#8217;s 2022 position statement say about the benefit-risk balance of hormone therapy?<\/p>\n<div class=\"msq-options\" role=\"group\" aria-label=\"Question 5 options\"><button type=\"button\" class=\"msq-opt\" data-opt=\"a\">It favours most healthy symptomatic women under 60 or within 10 years of menopause onset<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"b\">It is unfavourable at every age<\/button><button type=\"button\" class=\"msq-opt\" data-opt=\"c\">It applies only once menopause has fully finished<\/button><\/div>\n<p class=\"msq-explain\" hidden><span class=\"msq-verdict\"><\/span>The 2022 position statement says the benefit-risk ratio is favourable for treatment of bothersome symptoms in most healthy women under 60 or within 10 years of menopause onset, without contraindications. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35797481\/\" target=\"_blank\" rel=\"noopener\">The Menopause Society, 2022<\/a> <a class=\"msq-section\" href=\"#why-do-uk-and-us-pages-say-different-things-about-hrt\">Read the section<\/a><\/p>\n<\/li>\n<\/ol>\n<div class=\"msq-result\" hidden><\/div>\n<\/div>\n<\/details>\n<script>(function(){\n  if (window.__msqInit) { return; }\n  window.__msqInit = true;\n  var root = document.getElementById('ms-quiz');\n  if (!root) { return; }\n  var meta = { slug: root.getAttribute('data-slug'), category: root.getAttribute('data-category'),\n               list: root.getAttribute('data-list') || '1' };\n  function qs(el, s){ return el.querySelector(s); }\n  function qsa(el, s){ return Array.prototype.slice.call(el.querySelectorAll(s)); }\n  function track(name, params){\n    try { if (typeof gtag === 'function') { var p = params || {}; p.article = meta.slug; gtag('event', name, p); } } catch (e) {}\n  }\n  function jumpList(missed){\n    if (!missed.length) { return ''; }\n    return '<ul class=\"msq-jump\">' + missed.map(function(q){\n      return '<li><a href=\"' + q.getAttribute('data-section') + '\">' + q.getAttribute('data-title') + '<\/a><\/li>';\n    }).join('') + '<\/ul>';\n  }\n  function emailForm(){\n    return '<div class=\"msq-sub\"><p><strong>Get the next one.<\/strong> We publish new articles on ' + meta.category\n      + ' most weeks and recheck this page on Sundays. Email me when a new article goes up or this page changes.<\/p>'\n      + '<form class=\"msq-form\" method=\"post\" action=\"\/mail\/form.php\" novalidate>'\n      + '<input type=\"hidden\" name=\"list\" value=\"' + meta.list + '\">'\n      + '<input type=\"hidden\" name=\"name\" value=\"\">'\n      + '<label class=\"msq-hp\" aria-hidden=\"true\">Leave this empty<input type=\"text\" name=\"website\" tabindex=\"-1\" autocomplete=\"off\"><\/label>'\n      + '<input type=\"email\" name=\"email\" placeholder=\"you@example.com\" required aria-label=\"Email address\" autocomplete=\"email\">'\n      + '<button type=\"submit\" class=\"msq-btn\">Email me the updates<\/button>'\n      + '<a href=\"#\" class=\"msq-no\">No thanks<\/a>'\n      + '<p class=\"msq-privacy\">We store your email and this page\\'s topic, nothing else. Unsubscribe any time.<\/p>'\n      + '<\/form><p class=\"msq-msg\" aria-live=\"polite\"><\/p><\/div>';\n  }\n  \/* The autoresponder always answers 200 with its own page. A \".msg.err\" box means the\n     address was rejected, \"You're subscribed\" means accepted, and a redirect only happens\n     after a successful subscribe. Same reading as the landing pages on the other sites. *\/\n  function sendForm(form){\n    return fetch(form.getAttribute('action'), { method: 'POST', body: new FormData(form), credentials: 'same-origin', redirect: 'manual' })\n      .then(function(res){\n        if (res.type === 'opaqueredirect') { return { status: 'ok' }; }\n        if (res.status === 404) { return { status: 'notlive' }; }\n        if (!res.ok) { throw new Error('HTTP ' + res.status); }\n        return res.text().then(function(t){\n          var doc = new DOMParser().parseFromString(t, 'text\/html');\n          var err = doc.querySelector('.msg.err');\n          if (err) {\n            var m = err.textContent.trim();\n            if (\/something went wrong\/i.test(m)) { throw new Error(m); }\n            return { status: 'rejected', message: m };\n          }\n          if (\/you.re subscribed\/i.test(doc.body.textContent)) { return { status: 'ok' }; }\n          return { status: 'unknown' };\n        });\n      });\n  }\n  function wireForm(sub){\n    var form = qs(sub, '.msq-form'), msg = qs(sub, '.msq-msg');\n    qs(form, '.msq-no').addEventListener('click', function(e){\n      e.preventDefault();\n      sub.innerHTML = '<p class=\"msq-msg\">No problem. The Sunday refresh keeps this page current either way.<\/p>';\n      track('quiz_email', { result: 'declined' });\n    });\n    form.addEventListener('submit', function(e){\n      e.preventDefault();\n      var input = qs(form, 'input[name=email]'), btn = qs(form, '.msq-btn');\n      var email = input.value.trim(); input.value = email;\n      if (!\/^[^\\s@]+@[^\\s@]+\\.[^\\s@]+$\/.test(email)) { msg.textContent = 'That email does not look right.'; return; }\n      btn.disabled = true; btn.textContent = 'Sending';\n      function reset(){ btn.disabled = false; btn.textContent = 'Email me the updates'; }\n      sendForm(form).then(function(r){\n        if (r.status === 'ok' || r.status === 'unknown') {\n          sub.innerHTML = '<p class=\"msq-msg\"><strong>Done.<\/strong> We will email you when the next article on ' + meta.category\n            + ' goes up and when this page changes. If a confirmation email arrives, click it.<\/p>';\n          track('quiz_email', { result: r.status });\n          if (r.status === 'ok') { track('generate_lead', { method: 'quiz' }); }\n        } else if (r.status === 'notlive') {\n          msg.textContent = 'Sign up is not switched on yet for this site. Nothing was stored.'; reset();\n          track('quiz_email', { result: 'notlive' });\n        } else {\n          msg.textContent = r.message || 'Please check the email address and try again.'; reset();\n          track('quiz_email', { result: 'rejected' });\n        }\n      }).catch(function(){\n        msg.textContent = 'Could not reach the sign up service just now. Nothing was stored.'; reset();\n        track('quiz_email', { result: 'error' });\n      });\n    });\n  }\n  function finish(container, mode, score, total, missed){\n    var result = qs(container, '.msq-result');\n    track('quiz_complete', { mode: mode, score: score, total: total });\n    var h;\n    if (mode === 'pre') {\n      h = '<h3>You knew ' + score + ' of ' + total + ' before reading.<\/h3>';\n      h += (score === total) ? '<p>All of them. Read on anyway; the sections below carry the detail behind each answer.<\/p>'\n                             : '<p>The rest is below. Jump straight to what you missed:<\/p>' + jumpList(missed);\n      try { sessionStorage.setItem('msq-pre-' + meta.slug, String(score)); } catch (e) {}\n    } else {\n      var pre = null;\n      try { pre = sessionStorage.getItem('msq-pre-' + meta.slug); } catch (e) {}\n      h = '<h3>You got ' + score + ' of ' + total + '.<\/h3>';\n      if (pre !== null) { h += '<p>Before reading you had ' + pre + ' of ' + total + '.<\/p>'; }\n      if (missed.length) { h += '<p>Worth a second look:<\/p>' + jumpList(missed); }\n      h += emailForm();\n    }\n    result.innerHTML = h; result.hidden = false;\n    if (mode !== 'pre') { wireForm(qs(result, '.msq-sub')); }\n    result.scrollIntoView({ behavior: 'smooth', block: 'nearest' });\n  }\n  function setup(container, mode){\n    var qEls = qsa(container, '.msq-q'), answered = 0, score = 0, missed = [];\n    qEls.forEach(function(q){\n      var answer = q.getAttribute('data-answer'), opts = qsa(q, '.msq-opt'), explain = qs(q, '.msq-explain');\n      q.removeAttribute('data-done'); explain.hidden = true; qs(explain, '.msq-verdict').textContent = '';\n      opts.forEach(function(b){ b.disabled = false; b.classList.remove('is-right', 'is-wrong'); });\n      opts.forEach(function(b){\n        b.addEventListener('click', function(){\n          if (q.getAttribute('data-done')) { return; }\n          q.setAttribute('data-done', '1');\n          var ok = b.getAttribute('data-opt') === answer;\n          opts.forEach(function(o){ o.disabled = true; if (o.getAttribute('data-opt') === answer) { o.classList.add('is-right'); } });\n          if (ok) { score += 1; } else { b.classList.add('is-wrong'); missed.push(q); }\n          qs(explain, '.msq-verdict').textContent = ok ? 'Right. ' : 'Not quite. ';\n          explain.hidden = false;\n          answered += 1;\n          track('quiz_answer', { mode: mode, question: q.getAttribute('data-q'), correct: ok ? 1 : 0 });\n          if (answered === qEls.length) { finish(container, mode, score, qEls.length, missed); }\n        });\n      });\n    });\n  }\n  var box = qs(root, '.msq-box');\n  setup(root, 'pre');\n  if (box) { box.addEventListener('toggle', function(){ if (box.open) { track('quiz_open', { mode: 'pre' }); } }); }\n  \/* The end block sits far below this script, so it does not exist yet while this runs\n     during parsing. A delegated listener finds it at click time. *\/\n  document.addEventListener('click', function(e){\n    var startBtn = (e.target && e.target.closest) ? e.target.closest('.msq-start-test') : null;\n    if (!startBtn) { return; }\n    var end = startBtn.closest('.msq-end');\n    if (!end) { return; }\n    var mount = qs(end, '.msq-mount');\n    var clone = qs(root, '.msq-body').cloneNode(true);\n    var intro = qs(clone, '.msq-intro');\n    if (intro) { intro.textContent = 'The same five questions, now that you have read the page.'; }\n    var res = qs(clone, '.msq-result'); if (res) { res.hidden = true; res.innerHTML = ''; }\n    mount.innerHTML = ''; mount.appendChild(clone);\n    setup(mount, 'test');\n    startBtn.hidden = true;\n    track('quiz_open', { mode: 'test' });\n    mount.scrollIntoView({ behavior: 'smooth', block: 'start' });\n    var first = qs(mount, '.msq-opt'); if (first) { first.focus({ preventScroll: true }); }\n  });\n  \/* Shared tool behaviour: checklists remember their ticks on this device, and a chooser\n     shows the result for the option picked. Calculators carry their own small script. *\/\n  function initTools(){\n    qsa(document, '.msq-check').forEach(function(box){\n      var key = 'msq-check-' + meta.slug + '-' + (box.getAttribute('data-id') || 'x');\n      var boxes = qsa(box, 'input[type=checkbox]'), count = qs(box, '.msq-check-count');\n      var yes = qs(box, '.msq-verdict-yes'), no = qs(box, '.msq-verdict-no');\n      var saved = {};\n      try { saved = JSON.parse(localStorage.getItem(key) || '{}'); } catch (e) {}\n      boxes.forEach(function(cb, i){ if (saved[i]) { cb.checked = true; } });\n      function refresh(){\n        var n = boxes.filter(function(cb){ return cb.checked; }).length, state = {};\n        boxes.forEach(function(cb, i){ if (cb.checked) { state[i] = 1; } });\n        try { localStorage.setItem(key, JSON.stringify(state)); } catch (e) {}\n        if (count) { count.textContent = n + ' of ' + boxes.length + (box.getAttribute('data-verb') || ' done'); }\n        if (yes && no) { yes.hidden = n === 0; no.hidden = n !== 0; }\n      }\n      boxes.forEach(function(cb){ cb.addEventListener('change', function(){ refresh(); track('tool_check', { tool: box.getAttribute('data-id') }); }); });\n      refresh();\n    });\n    qsa(document, '.msq-choose').forEach(function(box){\n      var results = qsa(box, '.msq-choice-result');\n      qsa(box, 'input[type=radio]').forEach(function(r){\n        r.addEventListener('change', function(){\n          results.forEach(function(el){ el.hidden = el.getAttribute('data-for') !== r.value; });\n          track('tool_choose', { tool: box.getAttribute('data-id'), choice: r.value });\n        });\n      });\n    });\n  }\n  \/\/ read progress: how far down the article the reader has scrolled, fired once per quarter\n  (function(){\n    var art = root.closest('article') || root.parentNode, fired = {};\n    function check(){\n      var top = art.getBoundingClientRect().top + window.pageYOffset, h = art.offsetHeight || 1;\n      var seen = (window.pageYOffset + window.innerHeight - top) \/ h * 100;\n      [25, 50, 75, 100].forEach(function(m){ if (seen >= m && !fired[m]) { fired[m] = true; track('read_progress', { percent: m }); } });\n    }\n    window.addEventListener('scroll', check, { passive: true }); window.addEventListener('load', check);\n  })();\n  if (document.readyState === 'loading') { document.addEventListener('DOMContentLoaded', initTools); } else { initTools(); }\n})();<\/script>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\">This page quotes the guideline rather than paraphrasing it, recommendation by recommendation, checked on 30 September 2026. It does not say whether HRT suits you, what to take or at what strength. Those belong to you and a clinician who knows your history, and a website that claims otherwise is selling something.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"can-you-have-hrt-while-you-are-still-having-periods\">Can you have HRT while you are still having periods?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Nothing in the guideline says otherwise. <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng23\/chapter\/Recommendations\" target=\"_blank\" rel=\"noopener\">NICE guideline NG23<\/a>, last updated on 15 April 2026, uses the word perimenopause in its recommendations only in section 1.3, on identifying it. Recommendation 1.3.1 identifies perimenopause, without laboratory tests, in otherwise healthy people aged 45 or over who have vasomotor symptoms that have recently started and any changes in their menstrual cycle. Changing periods are part of the definition, not a reason to wait.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The HRT recommendations then talk about &quot;menopause-associated symptoms&quot; and set no requirement for periods to have ended. Recommendation 1.8.1 says to offer combined HRT, oestrogen with a progestogen, to people with a uterus, and oestrogen alone to people who have had a total hysterectomy. Section 1.4 covers everyone aged 40 or over; for 40 to 44, recommendation 1.6.6 says the balance of benefits and risks is likely to sit between that for premature ovarian insufficiency and that for people aged 45 or over. If you were told you are too young to be asking, <a href=\"https:\/\/pauseproof.com\/articles\/doctor-said-too-young-perimenopause\/\">what NICE actually says at each age<\/a> sets the bands out.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">One practical point matters more in perimenopause than after it. The <a href=\"https:\/\/www.nhs.uk\/medicines\/hormone-replacement-therapy-hrt\/about-hormone-replacement-therapy-hrt\/\" target=\"_blank\" rel=\"noopener\">NHS page on HRT<\/a> says it is still possible to get pregnant while taking HRT, and advises contraception until 2 years after the last period if you are under 50, or 1 year after it over 50. HRT is not contraception. We cover the detail in <a href=\"https:\/\/pauseproof.com\/articles\/can-menopausal-woman-get-pregnant\/\">when contraception can stop<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"which-symptoms-does-nice-say-hrt-is-for-and-which-is-it-not\">Which symptoms does NICE say HRT is for, and which is it not for?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">NICE chooses its verbs carefully. &quot;Offer&quot; means the committee was confident; &quot;consider&quot; means the evidence was weaker; &quot;do not offer&quot; means it should not happen. Here is how the guideline words HRT for each symptom or aim, with the recommendation number so you can check every row yourself.<\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><thead><tr><th>Symptom or aim<\/th><th>What NG23 says<\/th><th>Recommendation<\/th><\/tr><\/thead><tbody><tr><td>Hot flushes and night sweats<\/td><td>Offer HRT<\/td><td>1.5.1<\/td><\/tr><tr><td>Vaginal dryness, pain with sex, urinary discomfort<\/td><td>Offer vaginal oestrogen, including alongside systemic HRT<\/td><td>1.5.5<\/td><\/tr><tr><td>Depressive symptoms that do not meet a diagnosis of depression, starting with other menopause symptoms<\/td><td>Consider HRT<\/td><td>1.5.21<\/td><\/tr><tr><td>Diagnosed depression<\/td><td>Follow NICE&#8217;s depression guideline alongside NG23<\/td><td>1.5.23<\/td><\/tr><tr><td>Sleep problems linked to night sweats<\/td><td>Consider menopause-specific CBT, alone or with other options including HRT<\/td><td>1.5.24<\/td><\/tr><tr><td>Low sexual desire<\/td><td>Consider testosterone if HRT alone is not effective<\/td><td>1.5.25<\/td><\/tr><tr><td>Fragility fracture<\/td><td>Risk is lower while taking HRT and falls back once it stops<\/td><td>Table 1<\/td><\/tr><tr><td>Muscle mass and strength<\/td><td>Limited evidence HRT may help<\/td><td>Table 1<\/td><\/tr><tr><td>Preventing heart disease<\/td><td>Do not offer HRT for this<\/td><td>1.6.4<\/td><\/tr><tr><td>Preventing dementia<\/td><td>Do not offer HRT for this<\/td><td>1.6.5<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Two lines in that table get lost in the noise. HRT is for symptoms: NICE is explicit that it is not a heart or brain protection plan, whatever a podcast guest says. And for hot flushes alone, recommendation 1.5.4 says not to routinely offer SSRI or SNRI antidepressants or clonidine as the first choice. Recommendation 1.4.5 adds that the efficacy and safety of unregulated hormone preparations are unknown, which covers the gummy that promises to &quot;balance your hormones&quot; about as politely as a guideline can. We looked at the non-prescription side in <a href=\"https:\/\/pauseproof.com\/articles\/natural-relief-for-hot-flashes\/\">what the evidence says about natural relief for hot flashes<\/a>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1600\" height=\"900\" src=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/hormone-replacement-therapy-for-perimenopause-chart.png\" alt=\"Chart of how firmly NICE recommends hormone replacement therapy for perimenopause by symptom.\" class=\"wp-image-409\" srcset=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/hormone-replacement-therapy-for-perimenopause-chart.png 1600w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/hormone-replacement-therapy-for-perimenopause-chart-300x169.png 300w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/hormone-replacement-therapy-for-perimenopause-chart-1024x576.png 1024w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/hormone-replacement-therapy-for-perimenopause-chart-768x432.png 768w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/hormone-replacement-therapy-for-perimenopause-chart-1536x864.png 1536w\" sizes=\"auto, (max-width: 1600px) 100vw, 1600px\" \/><figcaption class=\"wp-block-image__caption\">NICE NG23 uses &#8220;offer&#8221; for its strongest recommendations, &#8220;consider&#8221; where evidence is weaker, and &#8220;do not offer&#8221; where evidence does not support using HRT.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The low desire row is the one NICE says least about, a single recommendation on testosterone. Our page on <a href=\"https:\/\/pauseproof.com\/articles\/perimenopause-sex-drive\/\">what the research and women report about perimenopause sex drive<\/a> takes that question further than a guideline table can.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-forms-of-hrt-exist-and-what-must-the-conversation-cover\">What forms of HRT exist, and what must the conversation cover?<\/h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1376\" height=\"768\" src=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/treatment-options-for-hormone-replacement-therapy-for-perimenopause-1.jpg\" alt=\"A modern transdermal patch representing options for hormone replacement therapy for perimenopause.\" class=\"wp-image-404\" srcset=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/treatment-options-for-hormone-replacement-therapy-for-perimenopause-1.jpg 1376w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/treatment-options-for-hormone-replacement-therapy-for-perimenopause-1-300x167.jpg 300w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/treatment-options-for-hormone-replacement-therapy-for-perimenopause-1-1024x572.jpg 1024w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/treatment-options-for-hormone-replacement-therapy-for-perimenopause-1-768x429.jpg 768w\" sizes=\"auto, (max-width: 1376px) 100vw, 1376px\" \/><figcaption class=\"wp-block-image__caption\">Different delivery methods offer personalized choices for managing midlife symptoms.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Systemic HRT, the kind absorbed into the bloodstream, delivers oestrogen as a tablet or through the skin as a patch, gel or spray, according to NICE&#8217;s own definitions. The progestogen that protects the womb lining comes as a tablet, a patch or an intrauterine system. Vaginal oestrogen is separate: recommendation 1.5.7 lists a cream, gel, tablet, pessary or ring, and 1.5.6 says only a minimal amount reaches the bloodstream compared with systemic HRT. What those genitourinary symptoms are, and why the condition goes by three different names, is set out in our guide to <a href=\"https:\/\/pauseproof.com\/articles\/vulvovaginal-atrophy\/\">vulvovaginal atrophy and what NICE says about it<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Recommendation 1.4.2 lists what a clinician should talk through when HRT is on the table: combined versus oestrogen-only, through the skin versus by mouth, the types of oestrogen and progestogen, sequential versus continuous combined, and dose and duration. 1.4.3 says to discuss how long treatment might last at the outset, to rediscuss benefits and risks at every review, and to explain that symptoms may return when HRT stops. 1.8.3 says to use the lowest effective dosage. 1.9.2 sets reviews at 3 months and then once a year. 1.5.28 says to consider HRT through the skin rather than by mouth for people at raised risk of blood clots, including a body mass index over 30. Side effects in the first weeks are part of that review too; our page on <a href=\"https:\/\/pauseproof.com\/articles\/hrt-bloating\/\">HRT bloating and what five leaflets list<\/a> covers the one the NHS page leaves out.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bleeding is the part to know in advance, stated plainly. Recommendation 1.8.4, amended in April 2026, says vaginal bleeding is common in the first 6 months of systemic HRT and within 3 months of any change, and that bleeding outside those windows needs prompt medical attention. <a href=\"https:\/\/pauseproof.com\/articles\/bleeding-after-menopause\/\">Bleeding after menopause<\/a> has its own page.<\/p>\n\n\n\n<div class=\"msq-tool msq-check\" data-id=\"hrt-appointment-checklist\" data-verb=\" covered\">\n<h3>Questions NICE expects to come up at an HRT appointment<\/h3>\n<p>Built from what NICE NG23 says a clinician should discuss before you start HRT. Tick off what you have covered; nothing here scores or recommends anything.<\/p>\n<label><input type=\"checkbox\">Whether combined HRT or oestrogen-only fits your situation<\/label>\n<label><input type=\"checkbox\">Patch, gel or spray versus a tablet, and why<\/label>\n<label><input type=\"checkbox\">The type of oestrogen and progestogen on offer<\/label>\n<label><input type=\"checkbox\">Sequential versus continuous combined HRT<\/label>\n<label><input type=\"checkbox\">The starting dose and how long treatment might run<\/label>\n<label><input type=\"checkbox\">What symptoms HRT is expected to help, and what it is not for<\/label>\n<label><input type=\"checkbox\">Whether vaginal oestrogen is worth adding for dryness or urinary symptoms<\/label>\n<label><input type=\"checkbox\">What counts as normal bleeding in the first six months, and when to get it checked<\/label>\n<p class=\"msq-check-count\"><\/p>\n<p class=\"msq-note\">This checklist follows NICE NG23&#8217;s own discussion points. It does not score your symptoms or tell you what to choose; that conversation is between you and a clinician who knows your history.<\/p>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-are-the-risks-of-hrt-in-nice-s-own-numbers\">What are the risks of HRT, in NICE&#8217;s own numbers?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">NICE publishes an <a href=\"https:\/\/www.nice.org.uk\/guidance\/ng23\/resources\/incidence-of-medical-conditions-with-and-without-hrt-a-discussion-aid-pdf-13553199901\" target=\"_blank\" rel=\"noopener\">HRT discussion aid<\/a> with absolute numbers per 1,000 women, meant to be read with a clinician. Its main estimates are for women aged 45 or over starting at 50, so they fit a 44 year old in perimenopause only roughly. The breast cancer figures combine sequential and continuous combined HRT.<\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><thead><tr><th>Outcome, per 1,000 women<\/th><th>Never took HRT<\/th><th>Took combined HRT<\/th><\/tr><\/thead><tbody><tr><td>Breast cancer, ages 50 to 69<\/td><td>59<\/td><td>79 after 5 years of use; 92 after 10 years<\/td><\/tr><tr><td>Fragility fracture, ages 50 to 54<\/td><td>60<\/td><td>40 after 5 years of use<\/td><\/tr><tr><td>Fragility fracture, ages 50 to 59<\/td><td>127<\/td><td>80 after 10 years of use<\/td><\/tr><tr><td>Endometrial cancer, ages 50 to 54<\/td><td>4<\/td><td>1 on continuous combined; 8 on sequential combined<\/td><\/tr><tr><td>Stroke, ages 50 to 54<\/td><td>3<\/td><td>Similar with oestrogen through the skin<\/td><\/tr><tr><td>Breast cancer, early menopause, ages 40 to 59<\/td><td>33<\/td><td>51 after 10 years from age 40<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Around those numbers the guideline adds three statements. Overall, combined or oestrogen-only HRT is unlikely to affect life expectancy (1.6.1). Breast cancer risk with combined HRT rises with duration, is higher in current than past users, and persists at least 10 years after stopping. Blood clot risk is raised with HRT by mouth and not with HRT through the skin. These are population figures; a personal history of breast cancer, clots, heart disease or stroke changes the conversation, and 1.5.26 and 1.5.30 route those cases to a clinician with menopause expertise.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"why-do-uk-and-us-pages-say-different-things-about-hrt\">Why do UK and US pages say different things about HRT?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Because they are working from documents of different ages, and the documents do not agree. The US pages that rank for this search lean on federal advice written before the labelling changed. Here is what each source says today.<\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><thead><tr><th>Source and date<\/th><th>On who<\/th><th>On how long<\/th><\/tr><\/thead><tbody><tr><td><a href=\"https:\/\/www.nice.org.uk\/guidance\/ng23\/chapter\/Recommendations\" target=\"_blank\" rel=\"noopener\">NICE NG23<\/a>, updated 15 April 2026<\/td><td>Offer HRT for vasomotor symptoms; no age ceiling in the recommendation<\/td><td>Discuss duration at the outset and at every review; lowest effective dosage<\/td><\/tr><tr><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35797481\/\" target=\"_blank\" rel=\"noopener\">The Menopause Society<\/a> (then NAMS), 2022 position statement<\/td><td>Benefit-risk favourable under 60 or within 10 years of menopause onset, without contraindications<\/td><td>Longer use for documented reasons, with periodic reevaluation<\/td><\/tr><tr><td><a href=\"https:\/\/www.sgo.org\/news\/fda-removes-black-box-warnings-on-hormone-replacement-therapy\/\" target=\"_blank\" rel=\"noopener\">US FDA<\/a>, announced 10 November 2025<\/td><td>Boxed warnings on heart disease, breast cancer and probable dementia removed<\/td><td>Not stated in the announcement<\/td><\/tr><tr><td><a href=\"https:\/\/womenshealth.gov\/menopause\/menopause-treatment\" target=\"_blank\" rel=\"noopener\">Office on Women&#8217;s Health<\/a>, page updated 11 March 2025<\/td><td>May be an option up to 59, usually within 10 years of menopause<\/td><td>&quot;Use the lowest dose that works for the shortest time needed&quot;<\/td><\/tr><tr><td><a href=\"https:\/\/www.nhs.uk\/medicines\/hormone-replacement-therapy-hrt\/about-hormone-replacement-therapy-hrt\/\" target=\"_blank\" rel=\"noopener\">NHS<\/a>, page last reviewed 7 February 2023<\/td><td>Usually possible if you have menopause symptoms<\/td><td>Usually 2 to 5 years, can be longer<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">One row in that table needs a second date beside it. The November 2025 announcement started the US change rather than finishing it. On 12 February 2026 the FDA approved the first updated labels, for six products, removing the boxed warning statements on heart disease, breast cancer and probable dementia, and said 29 companies had been asked to submit labelling changes, according to <a href=\"https:\/\/www.biospace.com\/press-releases\/fda-approves-labeling-changes-to-menopausal-hormone-therapy-products\" target=\"_blank\" rel=\"noopener\">the FDA announcement as republished by BioSpace<\/a>. So whether a particular US product still carries the old box depends on whether its own update has been approved yet. That is a question for the prescriber or pharmacist, not something a general page can settle.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">There is one outright contradiction. The FDA announcement says women who start HRT within 10 years of menopause onset, generally before 60, show a reduction in all-cause mortality in randomised studies. NICE recommendation 1.6.1 says HRT is unlikely to affect life expectancy overall. Both cannot be the whole picture, and neither is a reason on its own to take or avoid HRT. The shortest time wording, meanwhile, appears nowhere in NICE&#8217;s text, and the NHS page predates the 2024 NICE update.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-do-women-in-their-forties-report-when-they-ask-about-hr\">What do women in their forties report when they ask about HRT?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">To see how the guidance meets the surgery, we read a <a href=\"https:\/\/www.mumsnet.com\/talk\/am_i_being_unreasonable\/5537375-dr-saying-this-isnt-perimenopause\" target=\"_blank\" rel=\"noopener\">Mumsnet thread from 2 June 2026<\/a> in which a woman about to turn 43 said her GP called her far too young for perimenopause. We read the first two of its three pages, about 50 posts. A poll on the thread drew 191 votes, 93 percent saying she was not being unreasonable. What follows is what posters report, paraphrased, not findings.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1376\" height=\"768\" src=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/friends-discussing-hormone-replacement-therapy-for-perimenopause.jpg\" alt=\"Two friends discussing their experiences with hormone replacement therapy for perimenopause over tea.\" class=\"wp-image-405\" srcset=\"https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/friends-discussing-hormone-replacement-therapy-for-perimenopause.jpg 1376w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/friends-discussing-hormone-replacement-therapy-for-perimenopause-300x167.jpg 300w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/friends-discussing-hormone-replacement-therapy-for-perimenopause-1024x572.jpg 1024w, https:\/\/pauseproof.com\/articles\/wp-content\/uploads\/2026\/09\/friends-discussing-hormone-replacement-therapy-for-perimenopause-768x429.jpg 768w\" sizes=\"auto, (max-width: 1376px) 100vw, 1376px\" \/><figcaption class=\"wp-block-image__caption\">Sharing real experiences with peers helps normalize the transition through midlife.<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The opening poster said she wanted to discuss HRT options and had to ask several times before blood tests were booked. One reply described an older GP who kept saying you cannot be menopausal while still having periods; she paid for a specialist through work insurance. Another said it took nearly three years, and a run of contraceptives and antidepressants, before she was offered HRT. A poster who had a hysterectomy at 43, keeping her ovaries, said two GPs over about two years offered antidepressants and a meditation app.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Several posts cut the other way, and they deserve the same space. One said fibroids and other causes of heavy bleeding ought to be checked first. One poster reported that her own symptoms turned out to be an overactive thyroid. Another passed on a GP friend&#8217;s view that many women now put everything down to perimenopause. On blood tests the thread split: one poster said a test would settle it, and at least five said it would not.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Against the guideline, the pattern is mixed. The idea that periods must stop first is not in NG23; 1.3.1 builds cycle change into the definition. But at 43, recommendation 1.3.6 does let a clinician consider an FSH test, so the blood tests were within the guidance, and so is ruling out other causes. <a href=\"https:\/\/pauseproof.com\/articles\/perimenopause-blood-test-normal\/\">Why a normal hormone result settles little<\/a> explains the swing. Whether the antidepressants these posters describe were for hot flushes or for mood cannot be told from a forum post, so 1.5.4 cannot be applied to them. If mood is the main thing, <a href=\"https:\/\/pauseproof.com\/articles\/depression-and-perimenopause\/\">our page on depression in perimenopause<\/a> sets the documents side by side.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-has-changed-since-this-was-first-published\">What has changed since this was first published?<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Added in October 2026: the FDA row in the comparison table describes the 10 November 2025 announcement. The first approved label changes followed on 12 February 2026 for six products, with more pending, per <a href=\"https:\/\/www.biospace.com\/press-releases\/fda-approves-labeling-changes-to-menopausal-hormone-therapy-products\" target=\"_blank\" rel=\"noopener\">the FDA announcement as republished by BioSpace<\/a>. This page previously read as though every US label had already changed.<\/li>\n\n\n\n<li>Not rechecked on 18 October 2026: the NICE NG23 update date of 15 April 2026. The NICE site refused our automated check that day, so that date rests on our reading of 30 September 2026.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"frequently-asked-questions\">Frequently asked questions<\/h2>\n\n\n<div id=\"rank-math-faq\" class=\"rank-math-block\">\n<div class=\"rank-math-list \">\n<div id=\"faq-q-1\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Does HRT work as contraception?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>No. The <a href=\"https:\/\/www.nhs.uk\/medicines\/hormone-replacement-therapy-hrt\/about-hormone-replacement-therapy-hrt\/\" target=\"_blank\" rel=\"noopener\">NHS<\/a> says pregnancy is still possible while taking HRT and advises contraception until 2 years after the last period under 50, or 1 year after it over 50.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-2\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Do you need a blood test before HRT in perimenopause?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Not at 45 or over: NICE 1.3.1 identifies perimenopause from symptoms without laboratory tests. For people aged 40 to 45, 1.3.6 says a clinician may consider an FSH test. Our <a href=\"https:\/\/pauseproof.com\/articles\/perimenopause-symptom-diary\/\">symptom diary guide<\/a> covers what to bring instead.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-3\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Is vaginal oestrogen the same as HRT?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>It is a local treatment. NICE 1.5.6 says only a minimal amount is absorbed into the bloodstream compared with systemic HRT, and 1.5.5 says it can be used alongside systemic HRT.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-4\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">What does NICE list if HRT is unsuitable?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>It names menopause-specific CBT (1.5.2) and, for moderate to severe hot flushes when HRT is unsuitable, fezolinetant under its technology appraisal (1.5.3). 1.5.26 says to consider referral to a clinician with menopause expertise.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-5\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">Are compounded or unregulated hormones the same thing?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>NICE 1.4.5 says the efficacy and safety of unregulated hormone preparations are unknown. A seminar that sells them as the natural upgrade is making a claim the guideline does not.<\/p>\n\n<\/div>\n<\/div>\n<div id=\"faq-q-6\" class=\"rank-math-list-item\">\n<h3 class=\"rank-math-question \">What does NICE say happens when HRT is stopped?<\/h3>\n<div class=\"rank-math-answer \">\n\n<p>Recommendation 1.8.7 says tapering may limit symptoms coming back in the short term, but tapering or stopping at once makes no difference in the longer term. 1.4.3 says symptoms may return and restarting can be discussed.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n<div class=\"msq-end\" id=\"ms-quiz-end\">\n<p><strong>Finished the page?<\/strong> The same five questions from the top, to see what stuck.<\/p>\n<button type=\"button\" class=\"msq-btn msq-start-test\">Test Your Understanding of This Article<\/button>\n<div class=\"msq-mount\"><\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><em>This article is general information, not medical advice, and is not a substitute for care from a qualified healthcare professional. Speak to your doctor about your own situation.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>What NICE NG23 says about HRT in perimenopause, recommendation by recommendation: what it is for, what it is not for, the risks in NICE&#8217;s own numbers, and where UK and US advice disagree.<\/p>\n","protected":false},"author":1,"featured_media":403,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","rank_math_title":"Hormone Replacement Therapy for Perimenopause: NICE, Quoted","rank_math_description":"Hormone replacement therapy for perimenopause, quoted from NICE: offered for hot flushes, never for heart or dementia prevention, periods need not stop.","rank_math_focus_keyword":"hormone replacement therapy for perimenopause","rank_math_canonical_url":"","rank_math_breadcrumb_title":"","rank_math_facebook_title":"","rank_math_facebook_description":"","rank_math_facebook_image":"","rank_math_twitter_title":"","rank_math_twitter_description":"","rank_math_twitter_image":"","rank_math_pillar_content":"","rank_math_robots":[],"rank_math_advanced_robots":[]},"categories":[3],"tags":[],"class_list":["post-406","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-talking-to-your-doctor"],"_links":{"self":[{"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/posts\/406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/comments?post=406"}],"version-history":[{"count":8,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/posts\/406\/revisions"}],"predecessor-version":[{"id":763,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/posts\/406\/revisions\/763"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/media\/403"}],"wp:attachment":[{"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/media?parent=406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/categories?post=406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pauseproof.com\/articles\/wp-json\/wp\/v2\/tags?post=406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}